Clinical Trial Update: Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Pediatric Participants With IgG4-RD [Phase 2]

View source ↗

Summary

This clinical trial update outlines a Phase 2 study to evaluate the pharmacokinetics, pharmacodynamics, safety, and tolerability of the monoclonal antibody Ineb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunoglobulin G4-related Disease

Drugs mentioned

• Uplizna (inebilizumab)

Snippet

Sponsor: Amgen | Conditions: Immunoglobulin G4-related Disease | Phase 2 | Status: NOT_YET_RECRUITING